[1]
2026. BIOTECHNOLOGY-DRIVEN VACCINE MANUFACTURING AND QUALITY CONTROL FOR CARDIOVASCULAR PROTECTION: CHALLENGES AND PUBLIC HEALTH OPPORTUNITIES. Bioscience Insights. 3, 02 (Aug. 2026), 208–223.